NTLA
Intellia Therapeutics Inc
Biotechnology company focused on CRISPR gene editing
CUSIP: 45826J105HealthcareUS1 holder
Total Value
$58.50M
Total Shares
1.57M
Net Share Change
-451.9K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$58.50M1.57M shares
TRIM-451.9K(-22.4%)